Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation.
Several lines of evidence point out the relevance of nucleotide-binding oligomerization domain leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome as a pivotal player in regulating the integrity of intestinal homeostasis and shaping innate immune responses during bowel inflammation. Intensive research efforts are being made to achieve an integrated view about the protective/detrimental role of canonical and non-canonical NLRP3 inflammasome activation in the maintenance of intestinal microenvironment integrity. Evidence is also emerging that the pharmacological modulation of NLRP3 inflammasome could represent a promising molecular target for the therapeutic management of inflammatory immune-mediated gut diseases. The present review has been intended to provide a critical appraisal of the available knowledge about the role of canonical and non-canonical NLRP3 inflammasome activation in the dynamic interplay between microbiota, intestinal epithelium, and innate immune system, taken together as a whole integrated network regulating the maintenance/breakdown of intestinal homeostasis. Moreover, special attention has been paid to the pharmacological modulation of NLRP3 inflammasome, emphasizing the concept that this multiprotein complex could represent a suitable target for the management of inflammatory bowel diseases.
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Manchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK.
Carolina
C
Pellegrini
Department of Clinical and Experimental Medicine, University of Pisa , Pisa , Italy.
Luca
L
Antonioli
Manchester Collaborative Centre for Inflammation Research, University of Manchester , Manchester , UK.
Gloria
G
Lopez-Castejon
Department of Clinical and Experimental Medicine, University of Pisa , Pisa , Italy.
Corrado
C
Blandizzi
Department of Clinical and Experimental Medicine, University of Pisa , Pisa , Italy.
Matteo
M
Fornai
NLRP3; bowel inflammation; canonical; enteric microbiota; immune system; intestinal homeostasis; non-canonical